(Health-NewsWire.Net, December 27, 2016 ) The proteomics market is segmented on the basis of proteomics instrumentation technology such as protein micro array (biochips, micro array instruments), spectroscopy (Mass and NMR), X-ray crystallography, chromatography, electrophoresis, proteomics reagents, proteomics services (analytical lab services, protein identification, extraction, sequencing, data analysis, maintaining bioinformatics data bases). The market is driven by growing need of personalized medicines, new discoveries in the field of genomics, rise in funds for proteomics based research, growing research and development expenditure, advancement in technologies, new techniques, high output, high resolutions achiness and instruments have been developed, availability of private funds and rise in the Asian markets like China and Japan.
For more information about this report: http://www.reportsweb.com/global-proteomics-market-insights-opportunity-analysis-market-shares-and-forecast-2016-2022
The top 10 companies own 40 to 50 percent of the market. Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques. Proteomic reagents market is dominated by immunoassays. The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of personalized medicines and lengthy regulatory approval process, reduction in funds by the US government, which owes 40% of this market, highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research and market is limited to a few developed nations only. Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise. Proteomics is science with broad applications in the field of therapeutics and diagnostics. Growing R&D and emergence of new players will create more market opportunities. Major players in the proteomics market are Thermo Fischer scientific corporation , Agilent technologies , Luminex corporation , Sigma-Aldrich corporation , Danaher corporation , Bio-Rad corporation , Waters corporation , PerkinElmer , Affymetrix and others.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001329421/sample
Companies profiled 1. Genzyme Corporation 2. Thermo Fischer scientific corporation 3. Becton Dickinson and Co 4. BG medicine 5. Agilent technologies 6. Luminex corporation 7. Sigma-Aldrich corporation 8. Danaher corporation 9. Anaspec Inc 10. Asterand PLC 11. Applied biosystems Inc 12. Bayer technology 13. Bio-Rad corporation 14. Waters corporation 15. PerkinElmer 16. Affymetrix 17. GE healthcare 18. Genesystems Inc 19. Activx Biosciences Inc 20. Amgen Inc 21. Beckman coulter 22. Biacore International AB 23. Biocarta Inc 24. Bruker biosciences 25. Caliper Lifesciences 26. Cellzome AG 27. Commonwealth biotechnologies 28. Digilab biovision GmBH 29. Dionex Corp 30. Dualsystems biotech AG
This Publisher Report covers 1. Historical data 2. Revenue forecasts, growth rates and CAGR upto 2022 3. Industry Analysis 4. Competitive Analysis 5. Key geographic growth data 6. In-depth profiling of companies
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001329421/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|